EIF2AK4 and cancer: Considering the emergence of a cadre of GCN2 activators and inhibitors on the market, this work also holds practical implications in the use of these chemical agents for the treatment of chronic diseases such as cancer and in the prevention of secondary hypothermia in patients with compromised thermotolerance such as trauma and surgical patients.